未登录 Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma Grant, M.; Cipriani, B.; Corbin, A.; Miller, D.; Naylor, A.; Hughes, S.; McCarthy, T.; Ambarkhane, S.; Memon, D.; Millward, M.; 等. 低pH,高风险:一项探讨GPR65通路作为肾细胞癌新型治疗策略的叙事性综述。Cancers 2025, 17, 3883. [Google Scholar] [CrossRef] [PubMed] Michael Grant; Barbara Cipriani; Alastair Corbin; David Miller; Alan Naylor; Stuart Hughes; Tom McCarthy; Sumeet Ambarkhane; Danish Memon; Michael Millward; Sumanta Pal; Ignacio Melero 分享 收藏
分享 收藏
Validation of GPR35 as a novel cancer target in digestive tract cancers and discovery of potent, selective GPR35 inverse agonists Westcott, James; Luckhurst, Christopher A.; McKenzie, Grahame; Memon, Danish; Lin, Li-Chiung; Knight, Sinead; Blaikley, Elizabeth J.; Pearce, Martin; Warren, Hannah R.; Parker, Eleanor; Milligan, Graeme; Hughes, Stuart W.; McCarthy, Tom 分享 收藏
The translational biology of small molecule GPR65 inhibitors: shared effects between mouse models and human primary tumors highlight the unique transformative potential of targeting a genetically validated innate immune checkpoint Cipriani, Barbara; Corbin, Alastair; Miller, David; Naylor, Alan; Khan, Faraz; Milne, Gavin; Young, Barbara; Satchell, Rupert; Sarkar, Sourav; Quareshy, Mussa; Nika, Anastasia; Singh, Preeti; Knox, Gavin; Turner, Darryl; Sankaran, Satish; Basak, Nandini Pal; Bohn, Toszka; Bopp, Tobia; Koturan, Surya; Sun, Bo; Fairfax, Benjamin; McCarthy, Tom; Hughes, Stuart 分享 收藏
分享 收藏
分享 收藏
Defining optimal dose schedules for ATR inhibitors in combination with DNA damaging drugs: Informing clinical studies of VX-970, the first in -class ATR inhibitor Pollard, John; Reaper, Phil; Peek, Adele; Hughes, Stuart; Gladwell, Scott; Jones, Julie; Chiu, Peter; Wood, Mark; Tolman, Crystal; Mac Johnson; Littlewood, Peter; Penney, Marina; McDermott, Katherine; Hare, Brian; Fields, Scott Z.; Asmal, Mohammed; O'Carrigan, Brent; Yap, Timothy A. 分享 收藏
Pre -clinical combinations of ATR and PARP inhibitors: Defining target patient populations and dose schedule Pollard, John; Reaper, Phil; Peek, Adele; Hughes, Stuart; Djeha, Hakim; Cummings, Steven; Larbi, Karen; Penney, Marina; Sullivan, Jim; Takemoto, Darin; DeFranco, Chris 分享 收藏
VX-970, the first-in-class inhibitor of the DNA damage repair enzyme ATR Pollard, John; Reaper, Philip; Jones, Julie; Barnes, Christopher; Gladwell, Scott; Hughes, Stuart; Peak, Adele; Djeha, Hakim; Hall, Amy; Newsome, David; Wang, Yuxin; Boucher, Diane; Eustace, Brenda; Gu, Yong; Hare, Brian; Johnson, Mac; Milton, Sean; Murphy, Cheryl; Takemoto, Darin; Tolman, Crystal; Wood, Mark; Furey, Brinley; Penney, Marina; Li, Howard; Defranco, Christopher; Asmal, Mohammed; Fields, Scott 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏